Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Vyant Bio (VYNT)
OTHER OTC:VYNT
Vyant Bio (VYNT) Stock Price & Analysis
425 Followers
VYNT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.21 - $4.94
Previous Close$0.22
Volume5.56K
Average Volume (3M)181.82K
Market Cap
$1.40M
Enterprise Value-$6.41M
Total Cash (Recent Filing)$10.00M
Total Debt (Recent Filing)$2.20M
Price to Earnings (P/E)>-0.1
Beta0.93
Next Earnings
Aug 14, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.87
Shares Outstanding6,267,708
10 Day Avg. Volume742,335
30 Day Avg. Volume181,822
Standard Deviation0.36
R-Squared0.07
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)14.42
Price to Sales (P/S)-28.42
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-11.30
Enterprise Value/Gross Profit18.73
Enterprise Value/Ebitda0.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vyant Bio News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VYNT FAQ
What was Vyant Bio’s price range in the past 12 months?
Vyant Bio lowest stock price was $0.21 and its highest was $4.94 in the past 12 months.
What is Vyant Bio’s market cap?
Currently, no data Available
When is Vyant Bio’s upcoming earnings report date?
Vyant Bio’s upcoming earnings report date is Aug 14, 2023 which is in 77 days.
How were Vyant Bio’s earnings last quarter?
Currently, no data Available
Is Vyant Bio overvalued?
According to Wall Street analysts Vyant Bio’s price is currently Overvalued.
Does Vyant Bio pay dividends?
Vyant Bio does not currently pay dividends.
What is Vyant Bio’s EPS estimate?
Vyant Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vyant Bio have?
Vyant Bio has 6,267,708 shares outstanding.
What happened to Vyant Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vyant Bio?
Currently, no hedge funds are holding shares in VYNT
---
Vyant Bio Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
Vyant Bio
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.
---
Top 5 ETFs holding VYNT
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold VYNT. The ETFs are listed according to market value of VYNT within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---